CN102641352B - 一种柳茶有效部位提取物及其制备方法和用途 - Google Patents
一种柳茶有效部位提取物及其制备方法和用途 Download PDFInfo
- Publication number
- CN102641352B CN102641352B CN201210121224.9A CN201210121224A CN102641352B CN 102641352 B CN102641352 B CN 102641352B CN 201210121224 A CN201210121224 A CN 201210121224A CN 102641352 B CN102641352 B CN 102641352B
- Authority
- CN
- China
- Prior art keywords
- extract
- willow tea
- effective part
- sibiraea
- part extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 241001220680 Sibiraea Species 0.000 title abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000741 silica gel Substances 0.000 claims abstract description 15
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000036541 health Effects 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 9
- 238000010992 reflux Methods 0.000 claims abstract description 9
- 235000013402 health food Nutrition 0.000 claims abstract description 8
- 239000000654 additive Substances 0.000 claims abstract description 7
- 239000003208 petroleum Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 5
- 235000013361 beverage Nutrition 0.000 claims abstract description 4
- 241001122767 Theaceae Species 0.000 claims description 76
- 241000124033 Salix Species 0.000 claims description 75
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 238000002481 ethanol extraction Methods 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 11
- 238000003809 water extraction Methods 0.000 claims description 11
- 238000004809 thin layer chromatography Methods 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 230000000996 additive effect Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 238000010898 silica gel chromatography Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000002594 sorbent Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000001117 sulphuric acid Substances 0.000 claims description 4
- 235000011149 sulphuric acid Nutrition 0.000 claims description 4
- 235000008429 bread Nutrition 0.000 claims description 3
- 235000012970 cakes Nutrition 0.000 claims description 3
- 235000014510 cooky Nutrition 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 235000012149 noodles Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 235000013618 yogurt Nutrition 0.000 claims description 3
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 241000646858 Salix arbusculoides Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000006286 aqueous extract Substances 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000005238 degreasing Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 description 7
- 229930182478 glucoside Natural products 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- -1 caffeic acid glucose alcohol ester Chemical class 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 241000040929 Sibiraea angustata Species 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 3
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 241000681575 Sibiraea laevigata Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- LJJHXRRUVASJDX-UHFFFAOYSA-N (S)-(E)-Lupinic acid Natural products OCC(C)=CCNC1=NC=NC2=C1N=CN2CC(N)C(O)=O LJJHXRRUVASJDX-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- LJJHXRRUVASJDX-WWQRDVDESA-N L-lupinic acid Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2C[C@H]([NH3+])C([O-])=O LJJHXRRUVASJDX-WWQRDVDESA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- DTJLOZXIIDPIFA-OUOAPTIVSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC(\C=C\C(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)=CC=C1O DTJLOZXIIDPIFA-OUOAPTIVSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- DTJLOZXIIDPIFA-UHFFFAOYSA-N glucityl ferulate Natural products COC1=CC(C=CC(=O)OCC(O)C(O)C(O)C(O)CO)=CC=C1O DTJLOZXIIDPIFA-UHFFFAOYSA-N 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- QURCVMIEKCOAJU-HWKANZROSA-N isoferulic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1O QURCVMIEKCOAJU-HWKANZROSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 238000009936 smoking Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
人数(个) | 体重(kg) | |
试验组(前) | 50 | 82.4±6.7 |
试验组(后) | 50 | 78.6±4.1 |
试验组前后差值 | 3.8±2.9 | |
对照组(前) | 50 | 82.5±6.3 |
对照组(后) | 50 | 82.2±6.2 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210121224.9A CN102641352B (zh) | 2012-04-24 | 2012-04-24 | 一种柳茶有效部位提取物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210121224.9A CN102641352B (zh) | 2012-04-24 | 2012-04-24 | 一种柳茶有效部位提取物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102641352A CN102641352A (zh) | 2012-08-22 |
CN102641352B true CN102641352B (zh) | 2014-01-08 |
Family
ID=46654596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210121224.9A Expired - Fee Related CN102641352B (zh) | 2012-04-24 | 2012-04-24 | 一种柳茶有效部位提取物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102641352B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103304607B (zh) * | 2013-05-29 | 2016-01-13 | 何兰 | 从窄叶鲜卑花降脂减肥有效部位得到的单萜苷化合物及其应用 |
CN108938768A (zh) * | 2018-07-25 | 2018-12-07 | 甘肃奇正实业集团有限公司 | 一种提高鲜卑花或窄叶鲜卑花减肥功效的方法及得到的产品和应用 |
CN110810445B (zh) * | 2019-11-19 | 2021-06-01 | 西北民族大学 | 利用藏药柳茶提取液生物合成纳米银抑菌剂的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199900801T2 (xx) * | 1996-10-16 | 1999-07-21 | Unilever N.V. | Çamaşır yumuşatıcı bileşim. |
JP2001002579A (ja) * | 1999-06-21 | 2001-01-09 | Iskra Ind Co Ltd | 柳茶(生薬)を有効成分として含有する脂質代謝調節剤 |
JP4328750B2 (ja) * | 2005-09-13 | 2009-09-09 | イスクラ産業株式会社 | 新規な化合物、肥満改善剤、脂質代謝改善剤、血糖降下剤及び育毛改善剤 |
CN100525791C (zh) * | 2006-03-02 | 2009-08-12 | 兰州大学 | 鲜卑花属植物的用途 |
CN102188515B (zh) * | 2011-04-24 | 2012-12-12 | 兰州大学 | 植物柳茶的一种用途 |
-
2012
- 2012-04-24 CN CN201210121224.9A patent/CN102641352B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102641352A (zh) | 2012-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656286B (zh) | 缓解酒后不适及降低酒精性肝损伤的组合物及应用 | |
CN100998650A (zh) | 肉桂在治疗糖尿病上的用途及产品和其制备方法 | |
CN102091315A (zh) | 生姜与乌梅组合物、其制备方法及其在制备癌症放、化疗中减毒增效药物中的用途 | |
CN102284020A (zh) | 一种具有解酒保肝作用的组合物及其制备方法与应用 | |
CN106975012B (zh) | 一种降血糖的中药组合物及其制备方法 | |
CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
CN102579836B (zh) | 一种霍山石斛中药组合物及其制备方法 | |
CN110075216B (zh) | 一种具有辅助降血脂、减肥保肝作用的食品组合物及其制备方法、制剂与应用 | |
CN102641352B (zh) | 一种柳茶有效部位提取物及其制备方法和用途 | |
CN104523742B (zh) | 一种具有护肝和提高免疫作用的多糖组合物及其应用 | |
EP1289538A2 (en) | Compositions for enhancing therapeutic effects, containing herbals and/or nutritional supplements and/or minerals and/or vitamins | |
CN103977390A (zh) | 一种生姜洋葱药酒组合物的制备方法及其用途 | |
CN103920140A (zh) | 一种人用降糖减肥降脂复方制剂 | |
CN109620913B (zh) | 一种预防和/或治疗肥胖、高血糖的组合物 | |
CN102793767B (zh) | 一种治疗失眠症的三七药物组合物及其制备方法与应用 | |
CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN105747217A (zh) | 一种铁皮石斛组合物及其应用与制备方法 | |
CN101874818B (zh) | 一种降血压或降血脂的药物或保健品组合物及其制备方法和用途 | |
CN105360787A (zh) | 一种保健食品及其制备方法 | |
CN114515009B (zh) | 一种具有减肥降脂功效的组合物及其应用 | |
Abass | Therapeutic effect of Artemisia herba-alba aqueous extract added to classical therapy of acquired hyperlipidemia | |
Tanweer et al. | The prophylactic potential of Zingiber officinale flowers and leaves extract to mitigate hyperglycemia in Sprague Dawley rats | |
CN103285110B (zh) | 一种治疗高血脂症的中药及其制备方法 | |
TWI440465B (zh) | 用以降血脂的中草藥萃取混合物及其醫藥組合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170220 Address after: Hangzhou City, Zhejiang Province, 311231 block of South Xiaoshan economic and Technological Development Zone Spring Road No. 1 Patentee after: HANGZHOU TIANCHENG PHARMACEUTICAL Co.,Ltd. Address before: Block south of Xiaoshan economic and Technological Development Zone Hongda Road, Xiaoshan District of Hangzhou City, Zhejiang Province, No. 79 311231 Patentee before: HANGZHOU LIUCHA PHARMACEUTICAL Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170707 Address after: Hangzhou City, Zhejiang Province, 311231 block of South Xiaoshan economic and Technological Development Zone Spring Road No. 1 Patentee after: Hangzhou Tiancheng Pharmaceutical Research Institute Co.,Ltd. Address before: Hangzhou City, Zhejiang Province, 311231 block of South Xiaoshan economic and Technological Development Zone Spring Road No. 1 Patentee before: HANGZHOU TIANCHENG PHARMACEUTICAL Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140108 |